Lantern Pharma Inc., a leading artificial intelligence (AI) oncology drug discovery and development company, announced a strategic AI-driven collaboration with French biotechnology company, Oregon...
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline...
